Atıf İçin Kopyala
KORKMAZ S., KEKLİK M., Sivgin S., Yildirim R., TOMBAK A., Kaya M. E., ...Daha Fazla
TRANSFUSION AND APHERESIS SCIENCE, cilt.48, sa.3, ss.353-358, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
48
Sayı:
3
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1016/j.transci.2013.04.016
-
Dergi Adı:
TRANSFUSION AND APHERESIS SCIENCE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.353-358
-
Anahtar Kelimeler:
Thrombotic thrombocytopenic purpura, Therapeutic plasma exchange, Fresh frozen plasma, Complete response, HEMOLYTIC-UREMIC SYNDROME, SINGLE-CENTER EXPERIENCE, SYNDROME TTP-HUS, CLEAVING PROTEASE, IMPROVED SURVIVAL, MICROANGIOPATHIES, DEFICIENCY, RITUXIMAB, EFFICACY, STEROIDS
-
Van Yüzüncü Yıl Üniversitesi Adresli:
Evet
Özet
Thrombotic thrombocytopenic purpura (TIT) is a particular form of thrombotic microangiopathy typically characterized by thrombocytopenia, microangiopathic hemolytic anemia, fever, neurological abnormalities, and renal dysfunction. UP requires a rapid diagnosis and an adapted management in emergency. Daily sessions of therapeutic plasma exchange (TPE) remain the basis of management of UP. Also, UP is a rare disease that is fatal if it is not treated. TPE has resulted in excellent remission and survival rates in UP patients.